Literature DB >> 8228029

Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus.

G W Hynd1, K L Hern, E S Novey, D Eliopulos, R Marshall, J J Gonzalez, K K Voeller.   

Abstract

The neurologic basis of attention deficit-hyperactivity disorder (ADHD) is poorly understood. Based on previous studies that have implicated metabolic deficiencies in the caudate-striatal region in ADHD, we employed magnetic resonance imaging to investigate patterns of morphology of the head of the caudate nucleus in normal and ADHD children. In normal children, 72.7% evidenced a left-larger-than-right (L > R) pattern of asymmetry, whereas 63.6% of the ADHD children had the reverse (L < R) pattern of asymmetry of the head of the caudate nucleus. This reversal of normal asymmetry in ADHD children was due to a significantly smaller left caudate nucleus. The reversal in asymmetry of the head of the caudate was most notable in ADHD males. These results suggest that normal (L > R) morphologic asymmetry in the region of the caudate nucleus may be related to asymmetries observed in neurotransmitter systems implicated in ADHD. The behavioral symptoms of ADHD may reflect disinhibition from normal levels of dominant hemispheric control, possibly correlated with deviations in asymmetric caudate-striatal morphology and deficiencies in associated neurotransmitter systems.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228029     DOI: 10.1177/088307389300800409

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  47 in total

Review 1.  Neuroimaging in child and adolescent psychiatric disorders.

Authors:  P J Santosh
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

Review 2.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

3.  3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects.

Authors:  S K Madsen; A J Ho; X Hua; P S Saharan; A W Toga; C R Jack; M W Weiner; P M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

4.  The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task.

Authors:  Peter Manza; Sien Hu; Jaime S Ide; Olivia M Farr; Sheng Zhang; Hoi-Chung Leung; Chiang-shan R Li
Journal:  J Psychopharmacol       Date:  2016-01-11       Impact factor: 4.153

Review 5.  Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view.

Authors:  Marc Schneider; Wolfgang Retz; Andrew Coogan; Johannes Thome; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

Review 6.  The neurobiological profile of girls with ADHD.

Authors:  E Mark Mahone; Ericka L Wodka
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Quantitative magnetic resonance imaging of the brain in survivors of very low birth weight.

Authors:  L J Abernethy; M Palaniappan; R W I Cooke
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

8.  Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.

Authors:  Danielle C Turner; Andrew D Blackwell; Jonathan H Dowson; Andrew McLean; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.

Authors:  C J Vaidya; G Austin; G Kirkorian; H W Ridlehuber; J E Desmond; G H Glover; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Neuropsychological assessment of attention in adults with different subtypes of attention-deficit/hyperactivity disorder.

Authors:  L Tucha; O Tucha; R Laufkötter; S Walitza; H E Klein; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.